Search

Search Constraints

You searched for: Author/Creator Crivera, Concetta

Search Results

1. Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. (2nd December 2015)

2. An answer to "anticoagulant treatment of cancer‐associated venous thromboembolism: Interpreting real‐world data with caution". Issue 9 (7th August 2018)

3. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. (2nd September 2017)

5. Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism. Issue 1 (15th November 2017)

6. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma. Issue 1 (10th December 2021)

7. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin. (29th January 2019)

8. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018)

9. Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis. Issue 1 (30th May 2017)

10. Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials. (2nd July 2016)